Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Viralgen
San Sebastián, Gipuzkoa/Basque Country, Spainviralgen.com ↗
- Ownership
- Private
- Employees
- ~430
- Development stage
- Commercial
01
Overview
Viralgen specializes in the contract development and cGMP-compliant manufacturing of recombinant adeno-associated virus vectors used in gene therapies. Since its founding in 2017, it has supplied over 600 research batches to clients globally, supporting more than two dozen clinical trials across the US, Canada, and Europe. Its proprietary Pro10™ suspension platform enables rapid turnaround times—delivering clinical-grade material in under nine months—and industry-leading scalability. The company has played a key role as a manufacturing partner in advancing rare disease therapies into the clinic.
- Therapeutic areas
- OncologyRare DiseasesNeurology
- Modalities
- Gene therapyAdeno-associated virus (AAV) vectorRecombinant adeno-associated virus (rAAV) vector
- Industry
- Contract Manufacturing Organization
02
Partnerships
Trogenix – AAV gene therapy for glioblastomaCTNNB1 Foundation – Manufacturing new gene therapy for CTNNB1 SyndromeOrphan Therapeutics Accelerator Clinical Development Network – Manufacturing partner
Beyond the preview
Go deeper on Viralgen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Viralgen.